Research and Development

Showing 15 posts of 9578 posts found.

merckincweb

NICE approves Merck’s Keytruda for advanced skin cancer following ipilimumab treatment

October 7, 2015 Research and Development Merck, NHS, NICE, keytruda, skin cancer

The National Institute for Health and Care Excellence (NICE) has approved Merck’s Keytruda (pembrolizumab) for treating advanced skin cancer after …
aubagio

Sanofi MS treatment Aubagio slows brain atrophy in Phase III trial

October 7, 2015 Research and Development Genzyme, MS, Sanofi

Sanofi and its subsidiary Genzyme have announced that magnetic resonance imaging (MRI) data from the Phase III TEMSO study demonstrate …
aristada

FDA approves Alkermes schizophrenia treatment

October 6, 2015 Research and Development Alkermes, Aristada, FDA, schizophrenia

The US Food and Drug Administration (FDA) has approved Alkermes’s Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia. Aristada …
flu_vaccien_smaller

Flu jab reduces risk of stroke for two months

October 6, 2015 Research and Development flu vaccine, stroke

The risk of suffering a stroke is significantly reduced for up to two months after receiving a flu vaccine, a …
oral_insulin

Moving forward in diabetes

October 6, 2015 Research and Development Novo Nordiak, diabetes

As many as 387 million people worldwide are living with diabetes, and it is predicted that by 2035 more than …
turing_logo

After Daraprim, Turing Pharma submits first in-house candidate to FDA

October 6, 2015 Manufacturing and Production, Research and Development turing

Turing Pharma may have been on the end of some less-than-favourable media coverage in recent weeks, but the company is …
teva

Teva acquires Mexico’s Rimsa for $2.3 billion

October 5, 2015 Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions

Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …
medcity_bojo

Why London is at the heart of life sciences

October 5, 2015 Research and Development NHS

by Eliot ForsterWhatever disease you’re trying to cure, you can bet that somebody in London has it. That probably isn’t …
keytruda

FDA approves Merck’s Keytruda for advanced NSC lung cancer

October 5, 2015 Research and Development, Sales and Marketing BMS, NSCL, keytruda, lung cancer, merck sharp and dohme, opdivo

The US Food and Drug Administration has granted accelerated approval for Merck’s Keytruda (pembrolizumab) to treat patients with advanced (metastatic) …

Woodley Equipment to Attend Global Site Solutions Summit, Florida, USA

October 2, 2015 Manufacturing and Production, Research and Development woodley equipment

Woodley Equipment will attend the upcoming Global Site Solutions Summit in Florida, USAThe Global Site Solutions Summit is taking place …
stephen_gough

Professor Stephen Gough joins Novo Nordisk as senior principal clinical scientist

October 2, 2015 Medical Communications, Research and Development Novo Nordisk, Professor Stephen Gough

Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …
genzyme_logo

Genzyme opts into Alnylam’s Thrombosis program

October 2, 2015 Medical Communications, Research and Development Alnylam, Genzyme, Sanofi, haemophilia

Sanofi subsidiary Genzyme has elected to opt into Alnylam’s investigational ALN-AT3 hemophilia program for development and potential future commercialisation in …
sandoz_building

FDA accepts Sandoz submission for Amgen biosimilar

October 2, 2015 Medical Communications, Research and Development Amgen, FDA, Novartis, Sandoz, biosimilars

Sandoz, a Novartis company and a global leader in biosimilars, has announced today that the US Food and Drug Administration …
gene

Berg joins Genomics England project to sequence 100,000 genomes

October 2, 2015 Medical Communications, Research and Development Berg, Genomics england, artificial intelligence

Boston-based biopharmaceutical company Berg has announced it will join an industry collaboration with Genomics England, with the goal of sequencing …
lungs_shiz

Verona Pharma’s respiratory drug proves positive in study

October 1, 2015 Research and Development COPD, verona pharma

Verona Pharma has announced encouraging positive headline data of the third and final part of a randomised, clinical study in …
The Gateway to Local Adoption Series

Latest content